SLDB Solid Biosciences Inc. - Common Stock
$9,71
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$4–$11
77% of range
Analystenbewertung
BUY
19 analysts
Kursziel
$18
+82% upside
P/E (TTM)
-4.9
ROE
-79.5%
Nettogewinnmarge
—
SLDB Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$9.71
Marktkapitalisierung
$766M
P/E (TTM)
-4.9
EPS (TTM)
$-1.99
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-79.5%
Verschuldungsgrad
—
52W-Spanne
$4 – $11
SLDB Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2016-12-31
→
2022-12-31
EPS
$-1.99
2020-12-31
→
2025-12-31
Freier Cashflow
$-157M
2018-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
SLDB
Peer-Median
P/E (TTM)
-4.9
—
P/B (K/B)
4.3
3.4
Price / FCF (Kurs / FCF)
-4.9
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
SLDB
Peer-Median
ROA
-82.8%
-31.3%
ROE
-79.5%
-38.1%
ROIC
-99.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
SLDB
Peer-Median
Current Ratio (Liquiditätsgrad)
6.1
10.9
Quick Ratio
1.8
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
SLDB
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
SLDB
Peer-Median
SLDB Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
19 Analysten
- Starker Kauf 8 42,1%
- Kauf 10 52,6%
- Halten 1 5,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
11 Analysten · 2026-08-17
Median
$16.00
Mittelwert
$17.64
← Unter allen Zielen
$9.71
Tief
$11.00
Hoch
$26.00
Median-Ziel
$16.00
+64,9%
Mittelwert-Ziel
$17.64
+81,7%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.02%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.38 | $-0.48 | 0.10% |
| 31. März 2026 | $-0.52 | $-0.44 | -0.08% |
| 31. Dezember 2025 | $-0.53 | $-0.53 | -0.00% |
| 30. September 2025 | $-0.48 | $-0.45 | -0.03% |
| 30. Juni 2025 | $-0.42 | $-0.51 | 0.09% |
| 31. März 2025 | $-0.59 | $-0.57 | -0.02% |
| 31. Dezember 2024 | $-1.00 | $-0.82 | -0.18% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SLDB | $445M | -2.8 | — | — | -79.5% | — |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | — |
| CLYM | $191M | -4.5 | — | — | -34.6% | — |
| GERN | $845M | -10.2 | -60.2% | — | -34.4% | — |
| ANNX | $750M | -3.7 | — | — | -100.7% | — |
| OLMA | $2.03B | -13.4 | — | — | -39.4% | — |
| DSGN | $567M | -7.7 | — | — | -32.8% | — |
| CADL | $310M | -7.8 | — | — | -53.7% | — |
| FTH | — | — | — | — | — | — |
| IMMX | $277M | -5.9 | — | — | -59.8% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $8M | $14M | $0 | $0 | $0 | $0 | |
| R&D Expense | $140M | $96M | $77M | $78M | $59M | $65M | $95M | $58M | $40M | |
| SG&A Expense | $39M | $33M | $28M | $29M | $27M | $22M | $25M | $18M | $15M | |
| Operating Expenses | $179M | $130M | $104M | $115M | $86M | $88M | $119M | $76M | $55M | |
| Operating Income | $-179M | $-130M | $-104M | $-106M | $-72M | $-88M | $-119M | $-76M | $-55M | |
| Interest Income | $10M | $9M | $8M | $3M | $64.0K | $115.0K | $2M | $619.0K | $219.0K | |
| Other Non-op | $824.0K | $652.0K | $1M | $-381.0K | $2.0K | $1.0K | $515.0K | $270.0K | $1M | |
| Pretax Income | $-174M | $-125M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-174M | $-125M | $-96M | $-86M | $-72M | $-88M | $-117M | $-75M | $-52M | |
| EPS (Basic) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · | |
| EPS (Diluted) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · | |
| Shares (Basic) | 87,504,631 | 40,816,694 | 19,884,007 | 8,512,089 | 7,118,024 | 3,462,475 | · | · | · | |
| Shares (Diluted) | 87,504,631 | 40,816,694 | 19,884,007 | 8,512,089 | 7,118,024 | 3,462,475 | · | · | · | |
| EBITDA | $-179M | $-130M | $-104M | $-106M | $-72M | $-88M | · | $-76M | · |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $80M | $74M | $155M | $119M | $155M | $76M | $86M | $52M | |
| Short-term Investments | · | · | · | · | · | · | · | $36M | $17M | |
| Prepaid Expense | $16M | $8M | $6M | $6M | $15M | $4M | $3M | $6M | $1M | |
| Current Assets | $205M | $157M | $130M | $220M | $223M | $159M | $86M | $129M | $71M | |
| PP&E (Net) | $4M | $5M | $7M | $10M | $6M | $8M | $12M | $10M | $2M | |
| PP&E (Gross) | $18M | $18M | $19M | $21M | $18M | $17M | $16M | $12M | $3M | |
| Accum. Depreciation | $14M | $13M | $13M | $11M | $12M | $9M | $5M | $2M | $504.0K | |
| Other Non-current Assets | $223.0K | $366.0K | $209.0K | $175.0K | $94.0K | $209.0K | $209.0K | $209.0K | · | |
| Total Assets | $233M | $189M | $165M | $260M | $232M | $171M | $103M | $140M | $76M | |
| Accounts Payable | $3M | $4M | $2M | $3M | $4M | $3M | $7M | $4M | $5M | |
| Accrued Liabilities | $19M | $20M | $10M | $17M | $10M | $9M | $9M | $8M | $6M | |
| Current Liabilities | $33M | $30M | $15M | $23M | $24M | $24M | $18M | $12M | $11M | |
| Capital Leases | $19M | $21M | $23M | $24M | $275.0K | $2M | $4M | $859.0K | · | |
| Other Non-current Liabilities | · | · | · | $96.0K | · | $1M | · | $1M | · | |
| Total Liabilities | $53M | $51M | $38M | $49M | $24M | $39M | $23M | $14M | $11M | |
| Common Stock | $79.0K | $40.0K | $20.0K | $20.0K | $7.0K | $87.0K | $48.0K | $35.0K | · | |
| Retained Earnings | $-958M | $-783M | $-659M | $-563M | $-477M | $-405M | $-316M | $-199M | $-124M | |
| AOCI | $52.0K | $47.0K | $15.0K | $-68.0K | $-45.0K | $0 | $1.0K | $-5.0K | $-13.0K | |
| Stockholders' Equity | $180M | $137M | $126M | $212M | $208M | $132M | $80M | $125M | $-59M | |
| Liabilities + Equity | $233M | $189M | $165M | $260M | $232M | $171M | $103M | $140M | $76M | |
| Shares Outstanding | 78,967,888 | 40,468,141 | 20,386,606 | 19,556,732 | 7,356,017 | 84,893,994 | 45,987,571 | 35,432,460 | 0 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $2M | $3M | $4M | $3M | · | · | |
| Stock-based Comp | $17M | $11M | $8M | $8M | $13M | $12M | $14M | $6M | $5M | |
| Restructuring | · | · | $-63.0K | $7M | · | $2M | · | · | · | |
| Operating Cash Flow | $-156M | $-100M | $-94M | $-98M | $-78M | $-57M | $-93M | $-70M | $-43M | |
| CapEx | $1M | $654.0K | $2M | $3M | $1M | $899.0K | $4M | $8M | $2M | |
| Investing Cash Flow | $-58M | $-16M | $10M | $59M | $-91M | $7M | $25M | $-27M | $10M | |
| Stock Issued | · | · | $3M | $73M | $135M | $113M | $49M | · | · | |
| Net Stock Activity | · | · | $3M | $73M | $135M | $113M | · | · | · | |
| Financing Cash Flow | $194M | $122M | $3M | $75M | $135M | $129M | $58M | $132M | $77M | |
| Net Change in Cash | $-20M | $6M | $-81M | $36M | $-34M | $79M | $-10M | $35M | $44M | |
| Free Cash Flow | $-157M | $-101M | $-96M | $-101M | $-79M | $-57M | · | $-78M | · |
Rentabilität 6
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1315.2% | -530.5% | · | · | · | · | |
| Net Margin | · | · | · | -1062.3% | -530.0% | · | · | · | · | |
| EBITDA Margin | · | · | · | -1315.2% | -530.5% | · | · | · | · | |
| ROA | -82.8% | -70.5% | -45.2% | -34.9% | -35.8% | -64.3% | · | -69.3% | · | |
| ROE | -79.5% | -82.0% | -70.9% | -48.4% | -33.5% | -114.4% | · | -55.4% | · | |
| ROIC | -99.6% | · | · | · | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 5.2 | 8.9 | 9.8 | 9.4 | 6.5 | · | 10.3 | · | |
| Quick Ratio | 1.8 | 2.7 | 5.1 | 6.9 | 5.0 | 6.3 | · | 6.9 | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.0 | · | 0.0 | · |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -40.6% | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $8M | $14M | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-174M | $-125M | $-96M | $-86M | $-72M | $-88M | $-117M | $-75M | $-52M | |
| Market Cap | $445M | $162M | $125M | $105M | $2.90B | $9.65B | · | $14.24B | · | |
| P/E | -2.8 | -1.3 | -1.3 | -0.5 | -2.6 | -4.5 | · | · | · | |
| P/S | · | · | · | 13.0 | 212.7 | · | · | · | · | |
| P/B | 2.5 | 1.2 | 1.0 | 0.5 | 13.9 | 73.1 | · | 113.8 | · | |
| P / Tangible Book | 2.5 | 1.2 | 1.0 | 0.5 | 13.9 | 73.1 | · | · | · | |
| P / Cash Flow | -2.8 | -1.6 | -1.3 | -1.1 | -37.2 | -170.5 | · | -202.9 | · | |
| P / FCF | -2.8 | -1.6 | -1.3 | -1.0 | -36.6 | -167.9 | · | -182.7 | · | |
| Earnings Yield | -35.3% | -76.5% | -78.7% | -187.7% | -38.6% | -22.4% | · | · | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $44M | $46M | $38M | $39M | $32M | $31M | $31M | $27M | $19M | $19M | $15M | $17M | $20M | $25M | $21M | $14M | |
| SG&A Expense | $13M | $11M | $11M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $6M | $7M | $7M | $8M | $7M | |
| Operating Expenses | $57M | $57M | $49M | $48M | $42M | $40M | $40M | $35M | $28M | $27M | $22M | $23M | $27M | $32M | $35M | $21M | |
| Operating Income | $-57M | $-57M | $-49M | $-48M | $-42M | $-40M | $-40M | $-35M | $-28M | $-27M | $-22M | $-23M | $-27M | $-32M | $-35M | $-21M | |
| Interest Expense | · | · | · | · | · | · | · | · | $88.0K | $95.0K | · | · | $111.0K | $121.0K | · | · | |
| Interest Income | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $735.0K | |
| Other Non-op | $214.0K | $157.0K | $219.0K | $210.0K | $207.0K | $188.0K | $199.0K | $211.0K | $239.0K | $3.0K | $270.0K | $278.0K | $265.0K | $282.0K | $-355.0K | $-13.0K | |
| Income Tax | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-55M | $-57M | $-50M | $-46M | $-39M | $-39M | $-43M | $-33M | $-25M | $-24M | $-20M | $-21M | $-25M | $-30M | $-15M | $-20M | |
| EPS (Basic) | $-0.38 | $-0.52 | $-0.50 | $-0.48 | $-0.42 | $-0.59 | $-1.02 | $-0.79 | $-0.61 | $-0.64 | $-0.99 | $-1.05 | $-1.25 | $-1.54 | $-0.69 | $-2.71 | |
| EPS (Diluted) | $-0.38 | $-0.52 | $-0.67 | $-0.48 | $-0.42 | $-0.59 | $-1.02 | $-0.79 | $-0.61 | $-0.64 | $-0.99 | $-1.05 | $-1.25 | $-1.54 | $-0.69 | $-2.71 | |
| Shares (Basic) | 143,688,701 | 109,811,461 | -167,394,706 | 94,417,746 | 94,140,286 | 66,341,305 | -79,716,357 | 41,443,317 | 40,934,361 | 38,155,373 | -39,406,941 | 20,059,641 | 19,663,672 | 19,567,635 | -14,051,736 | 7,532,706 | |
| Shares (Diluted) | 143,688,701 | 109,811,461 | -167,394,706 | 94,417,746 | 94,140,286 | 66,341,305 | -79,716,357 | 41,443,317 | 40,934,361 | 38,155,373 | -39,406,941 | 20,059,641 | 19,663,672 | 19,567,635 | -14,051,736 | 7,532,706 | |
| EBITDA | $-57M | $-57M | · | $-48M | $-42M | $-40M | · | $-35M | $-28M | $-27M | · | $-23M | $-27M | $-32M | · | $-21M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $159M | $297M | $60M | $61M | $139M | $211M | $80M | $64M | $96M | $118M | $74M | $49M | $92M | $165M | $155M | $49M | |
| Prepaid Expense | $17M | $15M | $16M | $9M | $11M | $6M | $8M | $8M | $7M | $8M | $6M | $5M | $7M | $5M | $6M | $5M | |
| Current Assets | $395M | $397M | $205M | $245M | $279M | $313M | $157M | $179M | $198M | $214M | $130M | $148M | $167M | $191M | $220M | $148M | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $7M | $7M | $7M | $9M | $10M | $6M | |
| PP&E (Gross) | · | · | $18M | · | · | · | $18M | · | · | $19M | $19M | $19M | $19M | $19M | $21M | $16M | |
| Accum. Depreciation | · | · | $14M | · | · | · | $13M | · | · | $13M | $13M | $12M | $12M | $11M | $11M | $9M | |
| Other Non-current Assets | $138.0K | $183.0K | $223.0K | $247.0K | $278.0K | $319.0K | $366.0K | $475.0K | $515.0K | $175.0K | $209.0K | $315.0K | $181.0K | $238.0K | $175.0K | $422.0K | |
| Total Assets | $421M | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M | $249M | $165M | $185M | $205M | $230M | $260M | $184M | |
| Accounts Payable | $4M | $6M | $3M | $8M | $5M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $3M | $6M | $3M | $5M | |
| Accrued Liabilities | $18M | $19M | $19M | $19M | $17M | $15M | $20M | $13M | $10M | $10M | $10M | $11M | $11M | $12M | $17M | $10M | |
| Current Liabilities | $29M | $30M | $33M | $36M | $30M | $29M | $30M | $23M | $15M | $14M | $15M | $16M | $16M | $20M | $23M | $17M | |
| Capital Leases | $18M | $18M | $19M | $20M | $20M | $21M | $21M | $22M | $22M | $23M | $23M | $23M | $24M | $24M | $24M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $96.0K | · | |
| Total Liabilities | $47M | $49M | $53M | $56M | $50M | $49M | $51M | $45M | $38M | $38M | $38M | $40M | $41M | $46M | $49M | $41M | |
| Common Stock | $105.0K | $98.0K | $79.0K | $78.0K | $78.0K | $77.0K | $40.0K | $39.0K | $39.0K | $38.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $8.0K | |
| Retained Earnings | $-1.07B | $-1.01B | $-958M | $-908M | $-862M | $-823M | $-783M | $-741M | $-708M | $-683M | $-659M | $-638M | $-617M | $-593M | $-563M | $-548M | |
| AOCI | $-113.0K | $-13.0K | $52.0K | $48.0K | $-38.0K | $2.0K | $47.0K | $116.0K | $-15.0K | $-4.0K | $15.0K | $2.0K | $14.0K | $5.0K | $-68.0K | $-196.0K | |
| Stockholders' Equity | $374M | $374M | $180M | $218M | $258M | $294M | $137M | $167M | $193M | $211M | $126M | $144M | $164M | $184M | $212M | $143M | |
| Liabilities + Equity | $421M | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M | $249M | $165M | $185M | $205M | $230M | $260M | $184M | |
| Shares Outstanding | 105,125,366 | 98,394,720 | 78,967,888 | 77,882,685 | 77,602,741 | 77,492,959 | 40,468,141 | 38,930,203 | 38,551,059 | 37,833,689 | 20,386,606 | 20,061,751 | 20,044,389 | 19,573,132 | 19,556,732 | 7,533,081 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $391.0K | $395.0K | $467.0K | $376.0K | $386.0K | $407.0K | $488.0K | $405.0K | $1M | $327.0K | · | · | · | · | · | · | |
| Stock-based Comp | $6M | $5M | $6M | $4M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $-63.0K | · | $6M | $0 | |
| Operating Cash Flow | $-53M | $-47M | $-54M | $-33M | $-37M | $-32M | $-30M | $-24M | $-21M | $-25M | $-21M | $-18M | $-27M | $-28M | $-34M | $-20M | |
| CapEx | $150.0K | $165.0K | $565.0K | $85.0K | $377.0K | $126.0K | $204.0K | $15.0K | $286.0K | $149.0K | $90.0K | $383.0K | $536.0K | $506.0K | $856.0K | $839.0K | |
| Investing Cash Flow | $-134M | $45M | $47M | $-45M | $-33M | $-27M | $39M | $-11M | $-5M | $-38M | $45M | $-25M | $-48M | $37M | $66M | $15M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $48M | $239M | $5M | $1M | $-2M | $190M | $7M | $3M | $5M | $107M | $505.0K | $0 | · | · | $75M | $-1.0K | |
| Net Change in Cash | $-138M | $237M | $-1M | $-78M | $-72M | $130M | $16M | $-31M | $-22M | $44M | $25M | $-43M | $-73M | $9M | $106M | $-6M | |
| Free Cash Flow | · | $-47M | · | · | · | $-32M | · | · | · | $-25M | · | · | · | $-29M | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.0% | -14.8% | · | -18.9% | -14.6% | -13.3% | · | -16.5% | -11.5% | -10.2% | · | -11.4% | -11.9% | -13.8% | · | -9.4% | |
| ROE | -17.3% | -17.0% | · | -23.8% | -17.5% | -15.6% | · | -21.0% | -14.1% | -12.3% | · | -14.6% | -15.1% | -16.3% | · | -11.1% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.8 | 13.1 | · | 6.7 | 9.3 | 10.9 | · | 7.9 | 13.5 | 14.9 | · | 9.4 | 10.6 | 9.4 | · | 8.7 | |
| Quick Ratio | 5.6 | 9.8 | · | 1.7 | 4.7 | 7.3 | · | 2.8 | 6.5 | 8.2 | · | 3.1 | 5.8 | 8.1 | · | 2.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -315.8 | -282.8 | · | · | · | · | · | · |
Bewertung (TTM) 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-197M | $-181M | · | $-157M | $-137M | $-121M | · | $-103M | $-95M | $-100M | · | $-96M | $-100M | $-101M | · | $-89M | |
| Market Cap | $1.05B | $708M | · | $481M | $378M | $287M | · | $271M | $219M | $504M | · | $51M | $105M | $93M | · | $53M | |
| P/E | -5.5 | -3.6 | · | -2.9 | -2.2 | -1.5 | · | -2.3 | -1.6 | -3.0 | · | -0.4 | -0.6 | -0.4 | · | -0.6 | |
| P/B | 2.8 | 1.9 | · | 2.2 | 1.5 | 1.0 | · | 1.6 | 1.1 | 2.4 | · | 0.4 | 0.6 | 0.5 | · | 0.4 | |
| P / Tangible Book | 2.8 | 1.9 | · | 2.2 | 1.5 | 1.0 | · | 1.6 | 1.1 | 2.4 | · | 0.4 | 0.6 | 0.5 | · | 0.4 | |
| P / Cash Flow | · | -15.0 | · | · | · | -9.0 | · | · | · | -20.0 | · | · | · | -3.3 | · | · | |
| P / FCF | · | -14.9 | · | · | · | -9.0 | · | · | · | -19.9 | · | · | · | -3.3 | · | · | |
| Earnings Yield | -18.0% | -27.9% | · | -34.2% | -46.0% | -66.5% | · | -44.3% | -62.6% | -33.6% | · | -259.9% | -168.5% | -231.0% | · | -168.6% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | — | — | — | $8M | $14M |
| Betriebsgewinnmarge % | — | — | — | -1315.2% | -530.5% |
| Nettoergebnis | $-174M | $-125M | $-96M | $-86M | $-72M |
| Verwässerte EPS | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 6.1 | 5.2 | 8.9 | 9.8 | 9.4 |
| Quick Ratio | 1.8 | 2.7 | 5.1 | 6.9 | 5.0 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-157M | $-101M | $-96M | $-101M | $-79M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 167 Einreicher · $974.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 44 (+7 vs. Vorquartal) | 25 (+13 vs. Vorquartal) | 53 (0 vs. Vorquartal) | 39 (-1 vs. Vorquartal) | +6.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $120.240.899 | 12.036.126 | 12,34% | Aktien |
| PERCEPTIVE ADVISORS LLC | $118.947.393 | 11.906.646 | 12,21% | Aktien |
| Bain Capital Life Sciences Investors, LLC | $97.990.102 | 9.808.819 | 10,06% | Aktien |
| Siren, L.L.C. | $76.827.146 | 7.690.405 | 7,89% | Aktien |
| FMR LLC | $46.864.419 | 4.691.133 | 4,81% | Aktien |
| ARMISTICE CAPITAL, LLC | $42.737.220 | 4.278.000 | 4,39% | Aktien |
| STATE STREET CORP | $41.711.896 | 4.175.365 | 4,28% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $40.059.121 | 4.009.922 | 4,11% | Aktien |
| RTW INVESTMENTS, LP | $38.890.331 | 3.892.926 | 3,99% | Aktien |
| Deep Track Capital, LP | $35.614.969 | 3.565.062 | 3,66% | Aktien |
| JANUS HENDERSON GROUP PLC | $28.877.004 | 4.010.695 | 2,96% | Aktien |
| CITADEL ADVISORS LLC | $24.560.285 | 2.458.487 | 2,52% | Aktien |
| Alyeska Investment Group, L.P. | $22.782.035 | 2.280.484 | 2,34% | Aktien |
| Vestal Point Capital, LP | $21.578.400 | 2.160.000 | 2,22% | Aktien |
| AMERIPRISE FINANCIAL INC | $20.575.205 | 2.059.578 | 2,11% | Aktien |
| Redmile Group, LLC | $19.467.463 | 1.948.695 | 2,00% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $16.645.589 | 1.665.937 | 1,71% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $15.049.995 | 1.506.506 | 1,55% | Aktien |
| GOLDMAN SACHS GROUP INC | $14.106.819 | 1.412.094 | 1,45% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $11.524.834 | 1.153.637 | 1,18% | Aktien |
| BLAIR WILLIAM & CO/IL | $7.555.207 | 756.277 | 0,78% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.478.404 | 748.589 | 0,77% | Aktien |
| Woodline Partners LP | $6.734.019 | 674.076 | 0,69% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $6.677.816 | 668.450 | 0,69% | Aktien |
| Birchview Capital, LP | $6.655.298 | 666.196 | 0,68% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $6.028.685 | 603.472 | 0,62% | Aktien |
| Monashee Investment Management LLC | $4.995.000 | 500.000 | 0,51% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $4.942.353 | 494.730 | 0,51% | Aktien |
| Point72 Asset Management, L.P. | $4.475.600 | 448.008 | 0,46% | Aktien |
| STEMPOINT CAPITAL LP | $3.584.212 | 358.780 | 0,37% | Aktien |
| Boxer Capital Management, LLC | $2.997.000 | 300.000 | 0,31% | Aktien |
| Ally Bridge Group (NY) LLC | $2.557.030 | 255.959 | 0,26% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.441.566 | 244.401 | 0,25% | Aktien |
| J. Goldman & Co LP | $2.419.218 | 242.164 | 0,25% | Aktien |
| D. E. Shaw & Co., Inc. | $2.225.662 | 222.789 | 0,23% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.040.777 | 204.282 | 0,21% | Aktien |
| UBS Group AG | $1.881.587 | 188.347 | 0,19% | Aktien |
| ALGERT GLOBAL LLC | $1.872.316 | 187.419 | 0,19% | Aktien |
| Balyasny Asset Management L.P. | $1.780.747 | 178.253 | 0,18% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.628.740 | 163.037 | 0,17% | Aktien |
| Apis Capital Advisors, LLC | $1.598.400 | 160.000 | 0,16% | Aktien |
| Soleus Capital Management, L.P. | $1.498.500 | 150.000 | 0,15% | Aktien |
| CITIGROUP INC | $1.437.471 | 143.891 | 0,15% | Aktien |
| Qube Research & Technologies Ltd | $1.367.661 | 136.903 | 0,14% | Aktien |
| BlackRock, Inc. | $1.293.865 | 129.516 | 0,13% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $1.097.761 | 109.886 | 0,11% | Aktien |
| Bank of New York Mellon Corp | $1.081.707 | 108.279 | 0,11% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.081.038 | 108.212 | 0,11% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $1.071.717 | 107.279 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $1.049.627 | 105.068 | 0,11% | Aktien |
| Fisher Asset Management, LLC | $1.033.775 | 103.481 | 0,11% | Aktien |
| GOLDMAN SACHS GROUP INC | $999.000 | 100.000 | 0,10% | Kaufoption |
| ALPS ADVISORS INC | $998.161 | 99.916 | 0,10% | Aktien |
| XTX Topco Ltd | $889.450 | 89.034 | 0,09% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $820.179 | 82.100 | 0,08% | Aktien |
| Verition Fund Management LLC | $811.937 | 81.275 | 0,08% | Aktien |
| Quadrature Capital Ltd | $782.117 | 78.290 | 0,08% | Aktien |
| Quantum Private Wealth, LLC | $738.241 | 73.898 | 0,08% | Aktien |
| Rafferty Asset Management, LLC | $717.072 | 71.779 | 0,07% | Aktien |
| Trexquant Investment LP | $690.589 | 69.128 | 0,07% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $621.488 | 62.211 | 0,06% | Aktien |
| JANE STREET GROUP, LLC | $617.242 | 61.786 | 0,06% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $606.443 | 60.705 | 0,06% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $586.313 | 58.690 | 0,06% | Aktien |
| Vanguard Global Advisers, LLC | $585.324 | 58.591 | 0,06% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $575.604 | 57.618 | 0,06% | Aktien |
| Knott David M Jr | $561.518 | 56.208 | 0,06% | Aktien |
| BARCLAYS PLC | $552.167 | 55.272 | 0,06% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $498.672 | 69.260 | 0,05% | Aktien |
| BANK OF NOVA SCOTIA | $471.538 | 47.201 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $461.108 | 46.157 | 0,05% | Aktien |
| Virtus Investment Advisers, LLC | $457.802 | 45.826 | 0,05% | Aktien |
| DeepCurrents Investment Group LLC | $447.832 | 44.828 | 0,05% | Aktien |
| Ikarian Capital, LLC | $429.130 | 42.956 | 0,04% | Aktien |
| Quantinno Capital Management LP | $400.999 | 40.140 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $373.626 | 37.400 | 0,04% | Kaufoption |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $368.831 | 36.920 | 0,04% | Aktien |
| PROFUND ADVISORS LLC | $365.065 | 36.543 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $361.998 | 36.236 | 0,04% | Aktien |
| Creative Planning | $358.241 | 35.860 | 0,04% | Aktien |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $332.577 | 33.291 | 0,03% | Aktien |
| ArchPoint Investors | $312.947 | 31.326 | 0,03% | Aktien |
| Invesco Ltd. | $308.891 | 30.920 | 0,03% | Aktien |
| CITADEL ADVISORS LLC | $308.691 | 30.900 | 0,03% | Kaufoption |
| Engineers Gate Manager LP | $288.861 | 28.915 | 0,03% | Aktien |
| HSBC HOLDINGS PLC | $285.269 | 27.804 | 0,03% | Aktien |
| Atom Investors LP | $271.548 | 27.182 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $231.868 | 23.210 | 0,02% | Aktien |
| SFMG, LLC | $221.308 | 22.153 | 0,02% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $212.218 | 21.243 | 0,02% | Aktien |
| VANGUARD GROUP INC | $205.307 | 36.402 | 0,02% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $199.291 | 19.949 | 0,02% | Aktien |
| AXQ CAPITAL, LP | $197.193 | 19.739 | 0,02% | Aktien |
| CIBC Private Wealth Group LLC | $188.802 | 30.600 | 0,02% | Aktien |
| Skopos Labs, Inc. | $185.840 | 25.811 | 0,02% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $169.830 | 17.000 | 0,02% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $162.857 | 16.302 | 0,02% | Aktien |
| Lido Advisors, LLC | $159.700 | 15.986 | 0,02% | Aktien |
| China Universal Asset Management Co., Ltd. | $156.523 | 15.668 | 0,02% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $156.084 | 15.624 | 0,02% | Aktien |
Unternehmensinsider 29 Insider · 13 Führungskräfte · 14 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Alexander Cumbo | President and CEO | 29. Januar 2026 A | 235.405 | 0 | 4 | $-983.959 |
| Kevin Tan | CFO & Treasurer | 29. Januar 2026 A | 99.422 | 0 | 4 | $-329.544 |
| Jennifer Lynn Ziolkowski | CFO, Treasurer & Asst. Secy | 27. Januar 2021 M | 335.636 | 0 | 0 | $0 |
| David T Howton | Chief Operating Officer | 29. Januar 2026 A | 105.077 | 0 | 4 | $-433.595 |
| Pedro Alvaro Amorrortu | Chief Operating Officer | 23. Januar 2019 A | 162.746 | 0 | 0 | $0 |
| Gabriel Brooks | Chief Medical Officer | 29. Januar 2026 A | 89.466 | 0 | 3 | $-280.978 |
| Paul Herzich | Chief Technology Officer | 29. Januar 2026 A | 72.638 | 0 | 4 | $-274.125 |
| Jessie Hanrahan | Chief Regulatory Officer | 29. Januar 2026 A | 74.318 | 0 | 4 | $-297.374 |
| Jennifer Marlowe | CSO | 13. Februar 2024 A | 6.998 | 0 | 0 | $0 |
| Carl Ashley Morris | Chief Scientific Officer | 27. Januar 2023 M | 19.760 | 0 | 0 | $0 |
| Erin Powers Brennan | Chief Legal Officer, Secretary | 2. Mai 2022 A | — | 0 | 0 | $0 |
| Lynette Herscha | Chief Legal Officer | 27. Juli 2020 M | 160.859 | 0 | 0 | $0 |
| Jorge Armando Quiroz | Chief Medical Officer | 23. Januar 2019 A | 228.092 | 0 | 0 | $0 |
| Ian F Smith | Direktor | 2. Juli 2026 M | 138.145 | 0 | 0 | $0 |
| Clare Kahn | Direktor | 10. Juni 2026 A | 2.960 | 0 | 0 | $0 |
| Georgia Keresty | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Lynne Marie Sullivan | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Ilan Ganot | Direktor | 10. Juni 2026 A | 27.474 | 0 | 5 | $-82.352 |
| Adam Leo Stone | Direktor | 10. Juni 2026 A | — | 0 | 0 | $0 |
| Martin I Freed | Direktor | 10. Juni 2026 A | 53.763 | 0 | 0 | $0 |
| Sukumar Nagendran | Direktor | 10. Juni 2026 A | 34.258 | 0 | 0 | $0 |
| Adam Koppel | Direktor | 11. Januar 2024 A | 4.034.582 | 0 | 0 | $0 |
| Robert Luther Huffines | Direktor | 13. Dezember 2022 A | — | 0 | 0 | $0 |
| Rajeev Shah | Direktor | 16. Juni 2021 A | 8.709.882 | 0 | 0 | $0 |
| Matthew Bennett Arnold | Direktor | 10. Dezember 2020 A | 3.933.429 | 0 | 0 | $0 |
| Juan Andrey Zarur | Direktor | 2. Januar 2020 A | 10.189 | 0 | 0 | $0 |
| Boxer Capital, LLC | 10%-Eigentümer | 28. März 2019 S | 3.473.272 | 0 | 0 | $0 |
| Gilad David Hayeem | 10%-Eigentümer | 22. August 2018 G | 1.948.991 | 0 | 0 | $0 |
| Joel Solomon Zev Schneider | — | 14. März 2022 S | 236.270 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., Perceptive Xontogeny Venture Fund, LP ×11 Einreichungen | 14. August 2026 | 11,20% | Änderung | — | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×12 Einreichungen | 24. Juni 2026 | 11,90% | Änderung | — | SEC |
| BCLS SB Investco, LP, Bain Capital Life Sciences Fund II, L.P., BCLS II Investco, LP, BCIP Life Sciences Associates, LP, BCLS II Equity Opportunities, LP, Bain Capital Life Sciences Opportunities IV, L.P. ×12 Einreichungen | 10. März 2026 | 8,80% | Änderung | — | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×2 Einreichungen | 30. Juli 2019 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 32 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,69% | 6.132 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,16% | 266.224 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,06% | 5.360 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,05% | 580.274 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,03% | 50.645 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 35.267 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,03% | 2.880 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 96.646 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,02% | 370.123 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 2.011.320 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 350.536 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 452.695 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 41.246 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 263.560 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2.775 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 773.750 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 163.029 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 2.170 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 18.153 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 2.193 NS | 31. Mai 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2.475 NS | 30. April 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 7.422 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.366 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 55 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 19.273 NS | 30. April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 111.913 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 24.332 SH | 8. August 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 2.692 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 17.135 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.148.576 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.707 SH | 8. August 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 957 NS | 30. April 2026 | N-PORT |